Biotech | November 13, 2021
Moderna presents data from Phase 1 study of mRNA Triplet programme
The interim data combines three mRNAs into one therapy injected directly into the tumour
The interim data combines three mRNAs into one therapy injected directly into the tumour
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
Acute therapies continue to report strong growth compared to chronic ones.
The global wellness market is valued at more than US $ 1.5 trillion, with annual growth of 5-10 per cent
Telemedicine services like SAATH and E-Sanjeevani add a meta-layer to the primary health sector, thus helping upgrade the entire health care system of India
As part of the PMGDisha-CoWIN integration, Mercer | Mettl has aggregated the database of 5 crore Aadhaar-authenticated and registered candidates, which is now being utilized to deliver vaccinations to the last mile populace
Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells
The company expects revenue growth of 10-15 per cent in the US
Subscribe To Our Newsletter & Stay Updated
